Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Aging Neurosci.

Sec. Alzheimer's Disease and Related Dementias

Volume 17 - 2025 | doi: 10.3389/fnagi.2025.1571429

This article is part of the Research TopicAdvancing Early Alzheimer's Detection Through Multimodal Neuroimaging TechniquesView all 15 articles

Virtual Reality Navigation for the Early Detection of Alzheimer's disease

Provisionally accepted
Sayuri  ShimaSayuri Shima1Reiko  OhdakeReiko Ohdake1Yasuaki  MizutaniYasuaki Mizutani1Harutsugu  TatebeHarutsugu Tatebe2Riki  KoikeRiki Koike3Atsushi  KasaiAtsushi Kasai4Epifanio  BagarinaoEpifanio Bagarinao5Akihiro  UedaAkihiro Ueda1Mizuki  ItoMizuki Ito1Junichi  HataJunichi Hata6Shinsuke  IshigakiShinsuke Ishigaki7Junichiro  YoshimotoJunichiro Yoshimoto1Hiroshi  ToyamaHiroshi Toyama1Takahiko  TokudaTakahiko Tokuda2A  TakashimaA Takashima3Hirohisa  WatanabeHirohisa Watanabe1*
  • 1Fujita Health University, Toyoake, Japan
  • 2National Institutes for Quantum and Radiological Science and Technology (Japan), Chiba, Japan
  • 3Gakushuin University, Toshima, Tōkyō, Japan
  • 4MIG (Medical Innovation Group) Inc. Tokyo, Japan, Tokyo, Japan
  • 5Nagoya University, Nagoya, Aichi, Japan
  • 6Tokyo Metropolitan University, Hachioji, Tōkyō, Japan
  • 7Shiga University of Medical Science, Otsu, Shiga, Japan

The final, formatted version of the article will be published soon.

Objective:The development of non-invasive clinical diagnostics is paramount for the early detection of Alzheimer's disease (AD). Neurofibrillary tangles in AD originate from the entorhinal cortex, a cortical memory area that mediates navigation via path integration (PI). Here, we studied correlations between PI errors and levels of a range of AD biomarkers using a 3D virtual reality navigation system to explore PI as a non-invasive surrogate marker for early detection.Methods: We examined 111 healthy adults for PI using a head-mounted 3D VR system, AD-related plasma biomarkers (GFAP, NfL, Aβ40, Aβ42, and p-tau181), Apolipoprotein E (ApoE) genotype, and demographic and cognitive assessments. Covariance of PI and AD biomarkers was assessed statistically, including tests for multivariate linear regression, logistic regression, and predictor importance ranking using machine learning, to identify predictive relationships for PI errors.Results: We found significant positive correlations between PI errors with age and plasma GFAP, p-tau181, and NfL levels. Multivariate analysis identified significant correlations of plasma GFAP (t-value = 2.16, p = 0.0332) and p-tau181 (t-value = 2.53, p = 0.0128) with PI errors. Predictor importance ranking using machine learning and receiver operating characteristic curves identified plasma p-tau181 as the most significant predictor of PI. ApoE genotype and plasma p-tau181 showed positive and negative PI associations (ApoE: coefficient = 0.650, p = 0.037; p-tau181: coefficient = -0.899, p = 0.041). EC thickness exhibited negative correlations with age, mean PI errors, and GFAP, NfL, and p-tau181; however, none of these associations remained significant after adjusting for age in linear regression analyses.Conclusion: These findings suggest that PI quantified by 3D VR navigation systems may be useful as a surrogate diagnostic tool for the detection of early AD pathophysiology. The hierarchical application of 3D VR PI and plasma p-tau181, in particular, may be an effective combinatorial biomarker for early AD neurodegeneration. These findings advance the application of non-invasive diagnostic tools for early testing and monitoring of AD, paving the way for timely therapeutic interventions and improved epidemiological patient outcomes.

Keywords: AD, Alzheimer's disease, AUC, area under the curve, Aβ, amyloid β, EC, entorhinal cortex, GFAP, glial fibrillary acidic protein, MCI, mild cognitive impairment, P-tau181, tau

Received: 05 Feb 2025; Accepted: 28 Jul 2025.

Copyright: © 2025 Shima, Ohdake, Mizutani, Tatebe, Koike, Kasai, Bagarinao, Ueda, Ito, Hata, Ishigaki, Yoshimoto, Toyama, Tokuda, Takashima and Watanabe. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Hirohisa Watanabe, Fujita Health University, Toyoake, Japan

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.